| |
| |
|
| Insider
Information: |
Galindo Alejandro |
| Relationship: |
EVP Endocrine Business... |
| City: |
Westlake Village |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
777,075 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$3,356,964 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
777,075 |
|
|
| Total
Value |
$3,356,964 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
MannKind Corp |
MNKD |
EVP Endocrine Business... |
2022-08-22 |
777,075 |
2020-08-27 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
17 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| MNKD |
MannKind Corp |
EVP Endocrine Business Unit |
• – – |
2022-08-22 |
4 |
S |
$3.84 |
$17,771 |
D/D |
(4,615) |
777,075 |
0 |
% |
|
| MNKD |
MannKind Corp |
EVP Endocrine Business Unit |
• – – |
2022-07-31 |
4/A |
A |
$2.93 |
$14,650 |
D/D |
5,000 |
781,690 |
0 |
- |
|
| MNKD |
MannKind Corp |
EVP Endocrine Business Unit |
• – – |
2022-07-31 |
4 |
B |
$2.93 |
$14,650 |
D/D |
5,000 |
781,690 |
2.74 |
% |
|
| MNKD |
MannKind Corp |
EVP Endocrine Business Unit |
• – – |
2022-05-18 |
4/A |
A |
$3.19 |
$15,277 |
D/D |
4,789 |
776,690 |
0 |
- |
|
| MNKD |
MannKind Corp |
EVP Endocrine Business Unit |
• – – |
2022-05-18 |
4 |
D |
$3.19 |
$15,277 |
D/D |
(4,789) |
771,901 |
0 |
- |
|
| MNKD |
MannKind Corp |
EVP Endocrine Business Unit |
• – – |
2022-05-10 |
4 |
A |
$0.00 |
$0 |
D/D |
200,000 |
776,690 |
0 |
- |
|
| MNKD |
MannKind Corp |
Chief Commercial Officer |
• – – |
2022-02-28 |
4 |
B |
$2.71 |
$99,999 |
D/D |
36,900 |
576,690 |
2.74 |
% |
|
| MNKD |
MannKind Corp |
EVP Endocrine Business Unit |
• – – |
2022-02-28 |
4/A |
A |
$2.71 |
$99,999 |
D/D |
36,900 |
576,690 |
0 |
- |
|
| MNKD |
MannKind Corp |
EVP Endocrine Business Unit |
• – – |
2022-01-31 |
4/A |
A |
$3.17 |
$5,719 |
D/D |
1,804 |
539,790 |
0 |
- |
|
| MNKD |
MannKind Corp |
Chief Commercial Officer |
• – – |
2022-01-31 |
4/A |
B |
$3.17 |
$5,719 |
D/D |
1,804 |
539,790 |
2.74 |
- |
|
| MNKD |
MannKind Corp |
Chief Commercial Officer |
• – – |
2022-01-31 |
4 |
B |
$3.17 |
$7,399 |
D/D |
2,334 |
540,320 |
2.74 |
% |
|
| MNKD |
MannKind Corp |
Chief Commercial Officer |
• – – |
2021-08-27 |
4 |
D |
$4.91 |
$47,215 |
D/D |
(9,616) |
537,986 |
0 |
- |
|
| MNKD |
MannKind Corp |
Chief Commercial Officer |
• – – |
2021-07-30 |
4 |
B |
$2.99 |
$14,950 |
D/D |
5,000 |
547,602 |
2.74 |
% |
|
| MNKD |
MannKind Corp |
Chief Commercial Officer |
• – – |
2021-05-18 |
4 |
A |
$0.00 |
$0 |
D/D |
144,000 |
542,602 |
0 |
- |
|
| MNKD |
MannKind Corp |
Chief Commercial Officer |
• – – |
2020-12-08 |
4/A |
B |
$2.89 |
$100,000 |
D/D |
34,602 |
398,602 |
2.74 |
- |
|
| MNKD |
MannKind Corp |
Chief Commercial Officer |
• – – |
2020-08-27 |
4 |
A |
$0.00 |
$0 |
D/D |
364,000 |
364,000 |
0 |
- |
|
| MNKD |
MannKind Corp |
Chief Commercial Officer |
• – – |
2018-11-14 |
4 |
B |
$2.89 |
$100,000 |
D/D |
34,602 |
398,602 |
2.74 |
- |
|
17 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
